MedPath

ew drug treatment and mechanism of action of the central anticholinergic drug trihexylphenidyl in reducung posttraumatic nightmares and Fiashbacks in patients with posttraumtic stress disoder,and the occurrence hyposthesis of nightmares and flashbacks.

Not Applicable
Conditions
posttraumatic stress disorder.
Registration Number
JPRN-UMIN000028461
Lead Sponsor
SOGO PTSD INSTITUTE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
29
Inclusion Criteria

Not provided

Exclusion Criteria

Men and women aged under 20 and over 40 years old, pregnant women, lactating women were excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath